Clotiazepam

Clotiazepam

SCHEMBL44592

CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Clotiazepam. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 known ✓ P14867 4/20 0.55
GABRA5 known ✓ P31644 4/20 0.55
GABRA2 known ✓ P47869 4/20 0.55
GABRB2 known ✓ P47870 4/20 0.55
GABRG2 known ✓ P18507 3/20 0.45
GABRB3 known ✓ P28472 3/20 0.45
GABRA3 known ✓ P34903 3/20 0.45
GABRP known ✓ O00591 2/20 0.45
GABRD known ✓ O14764 2/20 0.45
GABRB1 known ✓ P18505 2/20 0.45
GABRA4 known ✓ P48169 2/20 0.45
GABRE known ✓ P78334 2/20 0.45
GABRA6 known ✓ Q16445 2/20 0.45
GABRG1 known ✓ Q8N1C3 2/20 0.45
GABRG3 known ✓ Q99928 2/20 0.45
GABRQ known ✓ Q9UN88 2/20 0.45
OPRK1 P41145 2/20 0.63
PDE4D Q08499 1/20 0.63
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clotiazepam SCHEMBL29368955 1.00 OPRK1 (0.63) OPRK1PDE4DGABRA1GABRA5GABRA2
Clotiazepam SCHEMBL28086544 0.91 OPRK1 (0.54) OPRK1PDE4DGABRA1GABRA5GABRA2
Etizolam SCHEMBL28086661 0.88 OPRK1 (0.85) OPRK1PDE4DPTAFRCYP3A4ALOX15
Clonazepam SCHEMBL14783900 0.82 GABRA1 (0.69) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL15652960 0.81 OPRK1 (0.59) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL8668108 0.81 OPRK1 (0.59) OPRK1PDE4DGABRA1GABRA5GABRA2
Clotiazepam SCHEMBL6130078 0.79 GABRA1 (0.64) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL8928481 0.79 OPRK1 (0.84) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL10825033 0.78 OPRK1 (0.42) OPRK1PDE4DGABRA1GABRA5GABRA2
SCHEMBL8668139 0.78 GAA (0.65) OPRK1PDE4DGABRA1GABRA5GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4694 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4611968-A1 METHOD AND CALIBRATION SYSTEM FOR CALIBRATING AUTONOMOUS MOBILE MACHINES Siemens Aktiengesellschaft (DE) 2025-09-10 EP claimed
EP-4570250-A2 COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER Otsuka Pharmaceutical Co., Ltd. (JP) 2025-06-18 EP claimed
US-20250179064-A1 BENZOQUINOLONE INHIBITORS OF VMAT2 AUSPEX PHARMACEUTICALS LLC 2025-06-05 US claimed
US-20250177385-A1 COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2025-06-05 US claimed
WO-2025111482-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS BEXSON BIOMEDICAL, INC. (US) 2025-05-30 WO claimed
CN-119648764-A Optical and SAR image registration method and system based on multi-scale phase antisymmetry 西安交通大学 2025-03-18 CN claimed
US-12133922-B2 Abuse resistant capsule R.P. SCHERER TECHNOLOGIES, LLC (US) 2024-11-05 US claimed
EP-3706762-B1 N4-HYDROXYCYTIDINE DERIVATIVE AND ANTI-VIRAL USES RELATED THERETO UNIV EMORY (US) 2024-10-16 EP claimed
WO-2024126774-A1 METHOD AND CALIBRATION SYSTEM FOR CALIBRATING AUTONOMOUS MOBILE MACHINES SIEMENS AKTIENGESELLSCHAFT (DE) 2024-06-20 WO claimed
US-20240156811-A1 COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-05-16 US claimed
US-4721709-A Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions PYARE SETH (CH) 1988-01-26 US claimed
EP-0247131-A1 PROCEDURE AND DEVICE FOR CROSSPOINT-SWITCHING OF SYNCHRONOUS OR ASYNCHRONOUS DATA TRANSMISSION LINES, PARTICULARLY FOR SERIAL DATA TRANSMISSION MTA KÖZPONTI FIZIKAI KUTATO INTEZETE (HU) 1987-12-02 EP claimed
WO-1987003447-A1 PROCEDURE AND DEVICE FOR CROSSPOINT-SWITCHING OF SYNCHRONOUS OR ASYNCHRONOUS DATA TRANSMISSION LINES, PARTICULARLY FOR SERIAL DATA TRANSMISSION MTA KÖZPONTI FIZIKAI KUTATÓ INTÉZETE (HU) 1987-06-04 WO claimed
EP-0216765-A1 OPTICAL RECEIVER. BELL TELEPHONE MFG (BE) 1987-04-08 EP claimed
WO-1985004997-A1 OPTICAL RECEIVER BELL TELEPHONE MANUFACTURING COMPANY, N.V. (BE) 1985-11-07 WO claimed
WO-1984001739-A1 ORGANIZATION APPARATUS FOR TRAVELLING, FOR THE OFFICE, THE SCHOOL AND AT HOME KOLLEKTIVGESELLSCHAFT EBERHARD (CH) 1984-05-10 WO claimed
EP-0025043-A1 LOCKING MEANS FOR SAFETY BELTS LINDBLAD, Stig Martin (US) 1981-03-18 EP claimed
EP-0020749-A1 EXCISING PATHOLOGICAL TISSUE USING A BEAM OF RADIATION DAVI, Samantha K. (US) 1981-01-07 EP claimed
WO-1980001877-A1 LOCKING MEANS FOR SAFETY BELTS LINDBLAD S M 1980-09-18 WO claimed
WO-1980001238-A1 EXCISING PATHOLOGICAL TISSUE USING A BEAM OF RADIATION DAVI S 1980-06-26 WO claimed